James Niedel - Managing Director @ New Leaf Venture Partners

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

James Niedel is the Managing Director at New Leaf Venture Partners.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Intarcia Therapeutics	New Leaf Venture Partners	No	Venture Round - Intarcia Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Intarcia Therapeutics	New Leaf Venture Partners	No	Venture Round - Intarcia Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Intarcia Therapeutics	New Leaf Venture Partners	—	Debt Financing - Intarcia Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Chimerix	New Leaf Venture Partners	Yes	Series F - Chimerix	obfuscated obfuscation
obfuscated obfuscation	Intarcia Therapeutics	New Leaf Venture Partners	—	Debt Financing - Intarcia Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Tioga Pharmaceuticals	New Leaf Venture Partners	No	Venture Round - Tioga Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	Intarcia Therapeutics	New Leaf Venture Partners	Yes	Venture Round - Intarcia Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Tioga Pharmaceuticals	New Leaf Venture Partners	—	Series A - Tioga Pharmaceuticals	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

is the

Managing Director

. Additionally,

has had

past jobs including

VP Research and SVP R&D

Organization Name	Title At Company	Start Date	End Date
GlaxoSmithKline	VP Research and SVP R&D	1988	1995
GlaxoSmithKline	Chief Science and Technology Officer	—	—
Duke University School of Medicine	Professor of Medicine and Chief of the division of Clinical Pharmacology	—	—

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

holds

board and advisor roles as

Board of Directors

and

Board Member

Organization Name	Title At Company	Start Date	End Date
Intarcia Therapeutics	Board Member	Mar 2007	—

Hub Name	CB Rank (Hub)
Female Founded Late Stage Venture Investors with Investments in Northeastern US	48,436
New York Female Founded Venture Capital Investors	57,597
Robertson Stephens Partners Alumni Founded Companies	93,055
United States Female Founded Post IPO Investors	95,432
Female Founded Early Stage Venture Investors with Investments in New York	28,565
Greater New York Area Investors with Funds Raised in 2024	80,126
New York Late Stage Venture Investors	22,098
Female Founded Venture Capital Investors with Investments in Greater New York Area	25,209
Female Founded Post IPO Investors with Investments in East Coast	96,624
Private Equity Stage Investors with Investments in New York	9,459